PURPOSE: To discuss common myths and misconceptions about long-acting reversible contraception (LARC) among patients and health care providers. METHODS: We address some of these common myths in an effort to provide clinicians with accurate information to discuss options with patients, parents, and referring providers. The list of myths was created through an informal survey of an online listserv of 200 family planning experts and from the experiences of the authors. RESULTS: When presented with information about LARC, adolescents are more likely to request LARC and are satisfied with LARC. Clinicians have an important role in counseling about and providing LARC to their adolescent patients as well as supporting them in managing associated side effects. CONCLUSIONS: This review article can be used as a resource for contraceptive counseling visits and for the continuing education of health professionals providing adolescent reproductive health care.
PURPOSE: To discuss common myths and misconceptions about long-acting reversible contraception (LARC) among patients and health care providers. METHODS: We address some of these common myths in an effort to provide clinicians with accurate information to discuss options with patients, parents, and referring providers. The list of myths was created through an informal survey of an online listserv of 200 family planning experts and from the experiences of the authors. RESULTS: When presented with information about LARC, adolescents are more likely to request LARC and are satisfied with LARC. Clinicians have an important role in counseling about and providing LARC to their adolescent patients as well as supporting them in managing associated side effects. CONCLUSIONS: This review article can be used as a resource for contraceptive counseling visits and for the continuing education of health professionals providing adolescent reproductive health care.
Authors: Amy Law; Dominic Pilon; Richard Lynen; François Laliberté; Laurence Gozalo; Patrick Lefebvre; Mei Sheng Duh Journal: Reprod Health Date: 2016-08-22 Impact factor: 3.223